Five things to know:
1. Researches included 327 patients who had spinal deformity surgery and five-year follow-up, and published methods helped determine costs based on CMS’s definitions. Cost utility was calculated with quality-adjusted life-years utilizing the Oswestry Disability Index. The cost-effectiveness threshold of $150,000 was used for primary analysis.
2. Major complication rates were 11%, and minor complication rates were 47%, and 26% of the patients had reoperation by five years.
3. Costs associated with one surgery was about $91,000.
4. Nineteen percent of patients met cost-effectiveness at two years after surgery. In cases where revision was avoided, 87% of the patients met cumulative cost-effectiveness until life expectancy.
5. The study concluded that “Most patients achieved cost-effectiveness after four years postoperatively, with 56% meeting at five years postoperatively. When revision was avoided, 87% of patients met cumulative cost-effectiveness till life expectancy. Mechanical complications were predictive of failure to achieve cost-effectiveness at two years, while comorbidity burden and medical complications were at five years.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
